CDH2 and kidney cancer: Next, protein expression of N-cadherin and E-cadherin were measured in four types of prostate (PC3, LNCAP), bladder (T24), kidney cancer cells (786-O), we found that treatment of metformin (5 mM) dramatically repressed N-cadherin expression, but without altering E-cadherin expression levels.